scispace - formally typeset
C

Claus Kristensen

Researcher at University of Copenhagen

Publications -  105
Citations -  3321

Claus Kristensen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Head and neck cancer & DAHANCA. The author has an hindex of 27, co-authored 95 publications receiving 2914 citations. Previous affiliations of Claus Kristensen include Novo Nordisk.

Papers
More filters
Journal ArticleDOI

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

TL;DR: The combination of the B31B32diArg and A21Gly substitutions provided insulin glargine with a 6- to 8-fold increased IGF-I receptor affinity and mitogenic potency compared with human insulin, and the reduced in vitro potency of insulin detemir might explain why this analog is not as effective on a molar basis as human insulin in humans.
Journal ArticleDOI

Alanine Scanning Mutagenesis of Insulin

TL;DR: The most striking finding is that B20Ala insulin retains high affinity binding to the receptor, and replacing GlyB20 with alanine most likely modifies the structure of the B-chain in this region, but this structural change appears to enhance binding toThe insulin receptor.
Journal ArticleDOI

Engineered CHO cells for production of diverse, homogeneous glycoproteins.

TL;DR: An engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential by constructing a design matrix that facilitates the generation of desired glycosylation, such as human-like α2,6-linked sialic acid capping.
Journal ArticleDOI

Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer

TL;DR: The independent influence of HPV-associated p16-expression in advanced OPC treated with primary RT was confirmed, however, RT-outcome in the group of non-OPC did not differ by tumor p 16-status, indicating that the prognostic impact may be restricted to OPC only.